Talaris Therapeutics, Inc. - stock earnings
Stock symbol TALS is outdated, potentially delisted? Maybe it is available on other exchange?
TALS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -14.7 million USD | ? USD |
| 2023Q1 | -20.9 million USD | ? USD |
| 2022Q4 | -15.0 million USD | ? USD |
| 2022Q3 | -18.2 million USD | ? USD |
| 2022Q2 | -17.8 million USD | ? USD |
| 2022Q1 | -18.1 million USD | ? USD |
| 2021Q4 | -14.2 million USD | ? USD |
| 2021Q3 | -12.9 million USD | ? USD |
| 2021Q2 | -11.4 million USD | ? USD |
| 2021Q1 | -9.3 million USD | ? USD |
| 2020Q4 | -6.8 million USD | ? USD |
| 2020Q3 | -6.4 million USD | ? USD |
| 2020Q2 | -4.7 million USD | ? USD |
| 2020Q1 | -4.8 million USD | ? USD |
TALS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -68.7 million USD | ? USD |
| 2021 | -48.2 million USD | ? USD |
| 2020 | -22.7 million USD | ? USD |
| 2019 | -17.9 million USD | ? USD |
TALS
Price: $2.72
52 week price:
Earnings Per Share: -0.34 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 1.8 million
Market Capitalization: 125.7 million